Category Archives: Uncategorized

The CMS Reimbursement Controversy: A Mixed Bag for 340B Hospitals

Dr. Jonathan Harrison, PharmD | President & COO In 2022, a landmark decision by the Supreme Court shook the healthcare…

Optimizing Mental Health Care: The Role of Clinical Psychiatric Pharmacists

By Dr. Ryan Paul | CEO Clinical psychiatric pharmacists play a crucial role in healthcare by specializing in the field…

Usage vs Impact: Evaluating the Significance of Pharmacy-Focused Digital Health Tools

Dr. Ryan Paul | CEO In recent years, digital health tools have revolutionized the way healthcare services are delivered, including…

A Powerful Movement for Global Public Health: The Connection Between Recovery and Mother Earth

By Dr. Dixie Brown and Dr. Ryan Paul Recovery from addiction is a complex and multifaceted journey that requires a…

Zurzuvae’s Approval: A Personal Reflection on New Hope for Postpartum Depression

By Jonathon Harrison, PharmD | President and COO The recent FDA approval of Zurzuvae (zuranolone), the first-ever oral medication for…

Community Health Series Part 2: Conference Confusion

By Robert Aanonsen, VP Business Development Immediately following the 2023 340B Summer Coalition Conference in Washington DC, articles were published…

Becoming the Community’s Pharmacy of Choice: The Power of FQHCs

By James Waddell | VP, Sales In today’s healthcare landscape, access to affordable and comprehensive pharmacy services are crucial. Federally…

Building Stronger Communities: A Holistic Approach to Ending HIV Transmission

A community-centered approach to eliminating HIV transmission involves empowering communities to take ownership of their own health and well-being. It…

Community Health Series Part 1: Must We Take The Blue Pill?

By Robert Aanonsen, VP Business Development Lower reimbursement rates, increased manufacturer 340B pricing restrictions, monopolization of the PBM landscape and…